About this episode

Dr. Schwartzman and Dr. Ruderman discuss PsA disease activity and treatment decisions involving JAKi.

Dr. Schwartzman and Dr. Ruderman discuss how PsA disease activity across GRAPPA domains may guide treatment decisions, sharing both the evidence for and their experience with a JAKi across domains.Sponsored by AbbVie Medical Affairs + Health Impact

People in this episode

Guests: Dr. Schwartzman, Dr. Ruderman

Topics covered

• PsA
• GRAPPA domains
• treatment decisions
• JAKi
• disease activity

Keywords

• PsA
• GRAPPA
• JAKi
• treatment
• disease activity

Sponsors

AbbVie Medical Affairs, Health Impact

More episodes of Rheumnow Podcast

• Follow the Money (4.23.2026) · April 24, 2026 · 26 min
• Prescribing Lessons (4.17.2026) · April 17, 2026 · 25 min
• Top Four and More (4.10.2026) · April 10, 2026 · 26 min
• Whats New PsA? (4.3.2026) · April 3, 2026 · 21 min
• Moral Distress (3.27.2026) · March 27, 2026 · 27 min
• DERM on RheumNow Podcast (March 2026) · March 27, 2026 · 15 min

Explore listener stats, chart rankings, contacts and more on the Rheumnow Podcast podcast page.